ResMed (NYSE:RMD) said late last week it filed a patent infringement petition with the US International Trade Commissions against competitor Fisher & Paykel Healthcare (NZE:FPH) in a continued spat between the companies. San Diego-based ResMed said they also filed a new lawsuit against Fisher & Paykel seeking monetary damages related to patent infringement from the company, as […]
ResMed ventilator now has autoEPAP
ResMed (NYSE:RMD) has added autoEPAP to its Astral life support ventilator in the United States. AutoEPAP (automatic expiratory positive airway pressure) automatically adjusts a patient’s expiratory pressure in response to flow limitations or obstruction of the upper airway. It’s an option when in Astral’s iVAPS (intelligent volume-assured pressure support) mode that automatically adapts to a patient’s […]
ResMed shares down as FY2018 earnings show shrinking profits
Shares in ResMed (NYSE:RMD) have fallen today after the medical device maker posted fourth quarter and full fiscal year 2018 earnings that topped expectations on the Street, but showed full year profits decline when compared to 2017. The San Diego-based company posted profits of $109.8 million, or 76¢ per share, on sales of $623.6 million for […]
ResMed, Google’s Verily ink sleep-apnea-focused joint venture deal
ResMed (NYSE:RMD) and Google (NSDQ:GOOG) life sciences company Verily said today they inked a new joint venture deal aiming to develop software solutions to improve diagnosis, treatment and care for sleep apnea and other breathing related sleep disorders. The new US-based joint venture will use sleep apnea knowledge from San Diego-based ResMed and Verily’s data analytics technologies in its […]
ResMed to acquire home and hospice software dev HealthcareFirst
ResMed (NYSE:RMD) said today it inked a deal to acquire healthcare software developer HealthcareFirst for an undisclosed amount. The soon-to-be acquired company develops software and services for both home health and hospice agencies, San Diego-based ResMed said. Offerings include electronic health record software, billing and coding services and advanced analytics for home and hospice settings. “Joining […]
ResMed touts cost efficiency in home oxygen, non-invasive ventilation therapy study
ResMed (NYSE:RMD) today released data from two clinical analyses exploring combined home oxygen therapy and non-invasive ventilation therapy for patients with persistent hypercapnia following a life-threatening exacerbation of chronic obstructive pulmonary disorder, touting an increase in cost efficiency with the combined therapy. Results from the two studies, performed in the U.K. and the US, were presented […]
ResMed posts Street-beating Q3
Shares in ResMed (NYSE:RMD) have fallen today despite the respiratory device maker beating expectations on Wall Street with its fiscal year 2018 third quarter earnings release. The San Diego, Calif.-based company posted profits of $110.1 million, or 76¢ per share, on sales of $591.6 million for the three months ended March 31, for bottom-line growth of […]
Sunrise Labs executes succession plan | Personnel Moves – April 5, 2018
Medical device and life science development group Sunrise Labs said this week that it completed its succession plan, with president Eric Soederberg acquiring the majority of shares in the company through a stock sale with founder and board chair Drew Sunstein. With the transaction, the Bedford, N.H.-based company said that it secured its planned ownership […]
ResMed is disrupting connected health: Here’s how
Here’s how a respiratory firm took control of the connected health and the medtech digital revolution. When you think powerful digital connected devices, the first thing to pop into your head probably isn’t a CPAP. Continuous positive airway pressure has been shown in numerous studies to be effective in improving sleep apnea and preventing a […]
5 medtech stories we missed this week: Jan. 26, 2018
From Attune Medical receiving FDA 510(k) clearance to Synapse Medical having CE Mark approval, here are 5 medtech stories we missed this week but thought were still worth mentioning. 1. Attune Medical gets FDA 510(k) clearance Attune Medical announced in a Jan. 8 press release that it has received FDA 510(k) clearance for its EnsoETM […]
ResMed tops Wall Street’s Q2 earnings forecast, despite $127m tax hit
The U.S. tax reform passed last year dealt a $127 million blow to ResMed (NYSE:RMD) during its fiscal second quarter, but the sleep apnea company still managed to top Wall Street’s consensus earnings forecast with its Q2 results. San Diego-based ResMed posted profits of $9.5 million, or 7¢ per share, on sales of $601.3 million for […]
- 1
- 2
- 3
- …
- 9
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
Google+